Hillsdale Investment Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Hillsdale Investment Management’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-92,941	Closed	-$1.77M	–	704
2019 Q1	$1.77M	Buy	+92,941	New	+$1.51M	0.16%	133

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Hillsdale Investment Management's OSIR Position: Q2 2019 in Review

Hillsdale Investment Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 92,941 shares — an estimated $1.77M sold.

Hillsdale Investment Management first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $1.77M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

Hillsdale Investment Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Hillsdale Investment Management sold 92,941 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.77M.
Hillsdale Investment Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
Hillsdale Investment Management's Osiris Therapeutics, Inc. Common Stock position peaked at $1.77M in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Hillsdale Investment Management's 13F filing for Q2 2019, filed 2 Aug 2019.